English

CREATIVE BIOMOLECULES INC

EDGAR

Quarterly report (10-Q) · filed 2000-07-28

19 filing records in this dataset, filed from 1996-05-14 to 2000-07-28. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

7.47 thousand USD

2000-06-30 · USD

Exact inputs and evidence

Revenue: 7471 USD Source

Operating margin

-40,999.09%

2000-06-30 · %

Exact inputs and evidence

Operating Income: -3063042 USD Source
Revenue: 7471 USD Source

Operating cash flow

-3.19 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -8288069 USD Source
Operating Cash Flow: -5097389 USD Source

Cash and cash equivalents: 13.6 million USD 2000-06-30 Source
Exact value

13551065 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.06 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Revenue: 1189750 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 3211860 USD · 1999-01-01 – 1999-12-31 Source
Revenue: 4023337 USD · 1999-01-01 – 1999-09-30 Source
Revenue: 670387 USD · 2000-01-01 – 2000-03-31 Source
Revenue: 7471 USD · 2000-04-01 – 2000-06-30 Source

Net income

-14.8 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Net income: -2994559 USD · 1999-07-01 – 1999-09-30 Source
Net income: -12109790 USD · 1999-01-01 – 1999-12-31 Source
Net income: -8631677 USD · 1999-01-01 – 1999-09-30 Source
Net income: -5841548 USD · 2000-01-01 – 2000-03-31 Source
Net income: -2514016 USD · 2000-04-01 – 2000-06-30 Source

Operating cash flow

-14.8 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Operating cash flow: -11676655 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -8302758 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -14768001 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -11676655 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -5097389 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -8288069 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -5097389 USD · 2000-01-01 – 2000-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-07-28.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-12-31
Operating income: 3 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 4 of 11 periods available· newest 1997-12-31
Total assets: 6 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1999-12-31
Current liabilities: 5 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-69.2%

Prior period

USD 10.43 million

1998-01-01 – 1998-12-31
Current period

USD 3.21 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

3211860 − 10429071 = -7217211 USD

10429071 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
3211860 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CREATIVE BIOMOLECULES INC · 1999-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Year-over-year change in Revenue: -7217211 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3211860 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2308 Input fundies:Revenue: 10429071 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2308
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 9.29 million

Prior period

−USD 21.4 million

1998-01-01 – 1998-12-31
Current period

−USD 12.11 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-12109790 − -21395138 = 9285348 USD

-21395138 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-12109790 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CREATIVE BIOMOLECULES INC · 1999-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Year-over-year change in Net income: 9285348 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -12109790 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2426 Input fundies:NetIncome: -21395138 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2426
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 4.36 million

Prior period

−USD 10.41 million

1998-01-01 – 1998-12-31
Current period

−USD 14.77 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-14768001 − -10411973 = -4356028 USD

-10411973 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-14768001 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CREATIVE BIOMOLECULES INC · 1999-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Year-over-year change in Operating cash flow: -4356028 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14768001 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442 Input fundies:OperatingCashFlow: -10411973 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 3.21 million 100% of revenue
Operating costs Derived USD 17.09 million 532% of revenue
Operating income −USD 13.87 million −432% of revenue
Tax, interest and other Derived −USD 1.76 million −55% of revenue
Net income −USD 12.11 million −377% of revenue

Cash

Operating cash flow −USD 14.77 million −460% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Operating loss: operating costs were 244% of revenue.
1998 Operating loss: operating costs were 323% of revenue.
1999 Operating loss: operating costs were 532% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	5807228	Unavailable	Unavailable	Unavailable	-18258606	-19363734 Derived	Source 1994-01-01 – 1994-12-31: 5807228 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -18258606 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -16414729 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 2949005 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	2004398	Unavailable	Unavailable	Unavailable	-3220102	-3064459 Derived	Source 1995-01-01 – 1995-12-31: 2004398 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -3220102 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -3016964 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 47495 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	22352210	Unavailable	Unavailable	Unavailable	-2239947	98263 Derived	Source 1996-01-01 – 1996-12-31: 22352210 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -2239947 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 3876541 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 3778278 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	13086401	31868617 Derived	-18782216	-2130543 Derived	-16651673	-20670593 Derived	Source 1997-01-01 – 1997-12-31: 13086401 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -18782216 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -16651673 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -17859982 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 2810611 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	10429071	33692768 Derived	-23263697	-1868559 Derived	-21395138	Unavailable	Source 1998-01-01 – 1998-12-31: 10429071 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -23263697 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -21395138 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -10411973 USD Inspect Operating Cash Flow Open source
1999 1999-01-01 – 1999-12-31	3211860	17086355 Derived	-13874495	-1764705 Derived	-12109790	Unavailable	Source 1999-01-01 – 1999-12-31: 3211860 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -13874495 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -12109790 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -14768001 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	5807228	Revenue: 5807228 Open source
19951995-12-31	Revenue	2004398	Revenue: 2004398 Open source
19961996-12-31	Revenue	22352210	Revenue: 22352210 Open source
19971997-12-31	Revenue	13086401	Revenue: 13086401 Open source
19981998-12-31	Revenue	10429071	Revenue: 10429071 Open source
19991999-12-31	Revenue	3211860	Revenue: 3211860 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-69.2% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 5807228 Open source
19951995-12-31	Year over year	-65.5%	Revenue: 2004398 Open source Revenue: 5807228 Open source
19961996-12-31	Year over year	1,015.2%	Revenue: 22352210 Open source Revenue: 2004398 Open source
19971997-12-31	Year over year	-41.5%	Revenue: 13086401 Open source Revenue: 22352210 Open source
19981998-12-31	Year over year	-20.3%	Revenue: 10429071 Open source Revenue: 13086401 Open source
19991999-12-31	Year over year	-69.2%	Revenue: 3211860 Open source Revenue: 10429071 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -432% 1999

Net margin -377% 1999

Free cash flow margin -158% 1997

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Operating margin	Not reported	Revenue: 5807228 Open source
1995-12-31	Operating margin	Not reported	Revenue: 2004398 Open source
1996-12-31	Operating margin	Not reported	Revenue: 22352210 Open source
19971997-12-31	Operating margin	-143.5%	Operating Income: -18782216 Open source Revenue: 13086401 Open source
19981998-12-31	Operating margin	-223.1%	Operating Income: -23263697 Open source Revenue: 10429071 Open source
19991999-12-31	Operating margin	-432%	Operating Income: -13874495 Open source Revenue: 3211860 Open source
19941994-12-31	Net margin	-314.4%	Net Income: -18258606 Open source Revenue: 5807228 Open source
19951995-12-31	Net margin	-160.7%	Net Income: -3220102 Open source Revenue: 2004398 Open source
19961996-12-31	Net margin	-10%	Net Income: -2239947 Open source Revenue: 22352210 Open source
19971997-12-31	Net margin	-127.2%	Net Income: -16651673 Open source Revenue: 13086401 Open source
19981998-12-31	Net margin	-205.1%	Net Income: -21395138 Open source Revenue: 10429071 Open source
19991999-12-31	Net margin	-377%	Net Income: -12109790 Open source Revenue: 3211860 Open source
19941994-12-31	Free cash flow margin	-333.4%	Revenue: 5807228 Open source Operating Cash Flow: -16414729 Open source Capital Expenditure: 2949005 Open source
19951995-12-31	Free cash flow margin	-152.9%	Revenue: 2004398 Open source Operating Cash Flow: -3016964 Open source Capital Expenditure: 47495 Open source
19961996-12-31	Free cash flow margin	0.4%	Revenue: 22352210 Open source Operating Cash Flow: 3876541 Open source Capital Expenditure: 3778278 Open source
19971997-12-31	Free cash flow margin	-158%	Revenue: 13086401 Open source Operating Cash Flow: -17859982 Open source Capital Expenditure: 2810611 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 10429071 Open source Operating Cash Flow: -10411973 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 3211860 Open source Operating Cash Flow: -14768001 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.8M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-16414729	Operating Cash Flow: -16414729 Open source
19951995-12-31	Operating cash flow	-3016964	Operating Cash Flow: -3016964 Open source
19961996-12-31	Operating cash flow	3876541	Operating Cash Flow: 3876541 Open source
19971997-12-31	Operating cash flow	-17859982	Operating Cash Flow: -17859982 Open source
19981998-12-31	Operating cash flow	-10411973	Operating Cash Flow: -10411973 Open source
19991999-12-31	Operating cash flow	-14768001	Operating Cash Flow: -14768001 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -20.7M 1997

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-19363734	Operating Cash Flow: -16414729 Open source Capital Expenditure: 2949005 Open source
19951995-12-31	Free cash flow	-3064459	Operating Cash Flow: -3016964 Open source Capital Expenditure: 47495 Open source
19961996-12-31	Free cash flow	98263	Operating Cash Flow: 3876541 Open source Capital Expenditure: 3778278 Open source
19971997-12-31	Free cash flow	-20670593	Operating Cash Flow: -17859982 Open source Capital Expenditure: 2810611 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -10411973 Open source
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: -14768001 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	Total Assets: 27470000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 32192000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 73818874 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 59038000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 66164000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 28892000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.84× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	13.16×	Current Assets: 23532061 Open source Current Liabilities: 1788746 Open source
19961996-12-31	Current assets / current liabilities	10.82×	Current Assets: 53080750 Open source Current Liabilities: 4906306 Open source
19971997-12-31	Current assets / current liabilities	8.49×	Current Assets: 36704247 Open source Current Liabilities: 4323730 Open source
19981998-12-31	Current assets / current liabilities	6.34×	Current Assets: 58905584 Open source Current Liabilities: 9292483 Open source
19991999-12-31	Current assets / current liabilities	4.84×	Current Assets: 21577645 Open source Current Liabilities: 4461317 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 18.26 million Exact value Exact value: -18258606 USD 1994-01-01 – 1994-12-31: -18258606 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1994-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -18258606 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18258606 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-97-001467.txt#2310 The citation records this snapshot. The page link may show a newer release later.	−USD 16.41 million Exact value Exact value: -16414729 USD 1994-01-01 – 1994-12-31: -16414729 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1994-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: -16414729 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16414729 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-97-001467.txt#2325 The citation records this snapshot. The page link may show a newer release later.	USD 2.95 million Exact value Exact value: 2949005 USD 1994-01-01 – 1994-12-31: 2949005 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CREATIVE BIOMOLECULES INC · 1994-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Capital Expenditure: 2949005 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2949005 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-97-001467.txt#2330 The citation records this snapshot. The page link may show a newer release later.	−USD 19.36 million Calculation and evidence -16414729 − 2949005 USD Exact free cash flow: -19363734 USD 1994-01-01 – 1994-12-31: -16414729 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 2949005 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CREATIVE BIOMOLECULES INC · 1994-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Free cash flow: -19363734 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16414729 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-97-001467.txt#2325 Input fundies:CapitalExpenditure: 2949005 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-97-001467.txt#2330 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 3.22 million Exact value Exact value: -3220102 USD 1995-01-01 – 1995-12-31: -3220102 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1995-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -3220102 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3220102 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2406 The citation records this snapshot. The page link may show a newer release later.	−USD 3.02 million Exact value Exact value: -3016964 USD 1995-01-01 – 1995-12-31: -3016964 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1995-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: -3016964 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3016964 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2421 The citation records this snapshot. The page link may show a newer release later.	USD 47,495 Exact value Exact value: 47495 USD 1995-01-01 – 1995-12-31: 47495 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CREATIVE BIOMOLECULES INC · 1995-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Capital Expenditure: 47495 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 47495 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.	−USD 3.06 million Calculation and evidence -3016964 − 47495 USD Exact free cash flow: -3064459 USD 1995-01-01 – 1995-12-31: -3016964 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 47495 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CREATIVE BIOMOLECULES INC · 1995-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Free cash flow: -3064459 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3016964 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2421 Input fundies:CapitalExpenditure: 47495 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 2.24 million Exact value Exact value: -2239947 USD 1996-01-01 – 1996-12-31: -2239947 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1996-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -2239947 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2239947 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-99-001661.txt#2341 The citation records this snapshot. The page link may show a newer release later.	USD 3.88 million Exact value Exact value: 3876541 USD 1996-01-01 – 1996-12-31: 3876541 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1996-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: 3876541 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3876541 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2421 The citation records this snapshot. The page link may show a newer release later.	USD 3.78 million Exact value Exact value: 3778278 USD 1996-01-01 – 1996-12-31: 3778278 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CREATIVE BIOMOLECULES INC · 1996-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Capital Expenditure: 3778278 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3778278 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.	USD 98,263 Calculation and evidence 3876541 − 3778278 USD Exact free cash flow: 98263 USD 1996-01-01 – 1996-12-31: 3876541 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 3778278 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CREATIVE BIOMOLECULES INC · 1996-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Free cash flow: 98263 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3876541 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2421 Input fundies:CapitalExpenditure: 3778278 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 16.65 million Exact value Exact value: -16651673 USD 1997-01-01 – 1997-12-31: -16651673 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1997-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -16651673 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16651673 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2426 The citation records this snapshot. The page link may show a newer release later.	−USD 17.86 million Exact value Exact value: -17859982 USD 1997-01-01 – 1997-12-31: -17859982 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1997-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: -17859982 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17859982 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442 The citation records this snapshot. The page link may show a newer release later.	USD 2.81 million Exact value Exact value: 2810611 USD 1997-01-01 – 1997-12-31: 2810611 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CREATIVE BIOMOLECULES INC · 1997-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Capital Expenditure: 2810611 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2810611 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.	−USD 20.67 million Calculation and evidence -17859982 − 2810611 USD Exact free cash flow: -20670593 USD 1997-01-01 – 1997-12-31: -17859982 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 2810611 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CREATIVE BIOMOLECULES INC · 1997-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Free cash flow: -20670593 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17859982 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442 Input fundies:CapitalExpenditure: 2810611 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000950135-98-001994.txt#2426 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 21.4 million Exact value Exact value: -21395138 USD 1998-01-01 – 1998-12-31: -21395138 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1998-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -21395138 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21395138 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2426 The citation records this snapshot. The page link may show a newer release later.	−USD 10.41 million Exact value Exact value: -10411973 USD 1998-01-01 – 1998-12-31: -10411973 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1998-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: -10411973 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10411973 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 12.11 million Exact value Exact value: -12109790 USD 1999-01-01 – 1999-12-31: -12109790 USD Inspect Net Income Open source Share or cite Citation for Net Income · CREATIVE BIOMOLECULES INC · 1999-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Net Income: -12109790 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12109790 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2426 The citation records this snapshot. The page link may show a newer release later.	−USD 14.77 million Exact value Exact value: -14768001 USD 1999-01-01 – 1999-12-31: -14768001 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CREATIVE BIOMOLECULES INC · 1999-12-31 CREATIVE BIOMOLECULES INC (edgar:857121) Operating Cash Flow: -14768001 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-03T23:51:21Z Snapshot: bd683b59201bf85b2a6b5d70f8ab0b40e4da305a9c90a257015ccd907e270285 Dimensions: Consolidated View: https://fundies.io/companies/edgar/857121/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14768001 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/857121/0000927016-00-002193.txt#2442 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0000857121, 857121, edgar:857121

Also known as CREATIVE BIOMOLECULES INCORPORATED

CREATIVE BIOMOLECULES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation